High-Risk Class D IVDs: Some Good News, Some Bad News About IVDR Implementation
Executive Summary
The European Commission’s just updated Rolling Implementation Plan for the MDR and IVDR shows delays in key structures for high-risk IVDs. Recent guidance clarifies how and when these products can still proceed to CE marking.
You may also be interested in...
MDR Amendment Proposal Likely To Be Adopted In Two Weeks’ Time
Amending the MDR to stem the flow of medtech products being withdrawn from the market has long been seen as urgent. It looks like the EU is keeping its foot on the accelerator to adopt its latest proposal despite concerns raised about the text.
Moves For Go Ahead For MDR Proposal To Be Discussed At European Parliament
The European Commission’s proposal to extend transition timelines for legacy devices in the context of the Medical Device Regulation is already on the move. There are still questions, however, about whether a fast-track adoption is in the best interests of the medtech sector.
Notified Bodies Follow Expert Panel Opinions Under EU MDR To The Letter
A review of expert panel opinions related to high-risk medical devices shows no challenges yet by notified bodies to their findings.